HighVista Strategies LLC

Source: SEC Form 13F · as of Mar 2026

HighVista Strategies LLC holds 79 biotech & pharma companies tracked by BioSniper, totaling $235.7M in value as of Mar 2026 (SEC Form 13F).

Companies held

79

Total value held

$235.7M

CompanySharesValue
ABVXAbivax SA113,254$12.6M
PRAXPraxis Precision Medicines, Inc.26,323$8.5M
COGTCogent Biosciences, Inc.197,051$7.6M
SYRESpyre Therapeutics, Inc.146,264$7.4M
PCVXVaxcyte, Inc.124,647$7.2M
RVMDREVOLUTION MEDICINES, INC.69,309$6.7M
TERNTerns Pharmaceuticals, Inc.114,307$6.0M
GPCRStructure Therapeutics Inc.123,909$6.0M
NUVLNuvalent, Inc.56,602$5.8M
IMVTImmunovant, Inc.225,139$5.6M
SLNOSOLENO THERAPEUTICS INC165,227$5.5M
TYRATyra Biosciences, Inc.131,304$5.0M
AMLXAmylyx Pharmaceuticals, Inc.352,085$4.9M
LBRXLB PHARMACEUTICALS INC173,595$4.3M
RLAYRelay Therapeutics, Inc.421,881$4.2M
INSMINSMED Inc24,316$4.0M
ORKAOruka Therapeutics, Inc.78,911$3.9M
CYTKCYTOKINETICS INC58,643$3.9M
LQDALiquidia Corp99,744$3.8M
OCULOCULAR THERAPEUTIX, INC441,573$3.7M
TARSTarsus Pharmaceuticals, Inc.52,464$3.7M
BBIOBridgeBio Pharma, Inc.49,560$3.7M
MLTXMoonLake Immunotherapeutics193,955$3.6M
ARGXARGENX SE4,918$3.6M
PTGXProtagonist Therapeutics, Inc33,852$3.6M
PALIPALISADE BIO, INC.2,019,326$3.5M
DFTXDefinium Therapeutics Inc.185,856$3.5M
NRIXNurix Therapeutics, Inc.226,546$3.5M
AXSMAxsome Therapeutics, Inc.20,437$3.5M
IVAInventiva S.A.615,666$3.4M
DYNDyne Therapeutics, Inc.182,929$3.3M
APGEApogee Therapeutics, Inc.35,761$3.0M
GHRSGH Research PLC213,212$3.0M
DNTHDianthus Therapeutics, Inc. /DE/35,587$3.0M
MAZEMaze Therapeutics, Inc.99,850$3.0M
ERASErasca, Inc.181,069$2.9M
EWTXEdgewise Therapeutics, Inc.91,931$2.9M
ELVNEnliven Therapeutics, Inc.73,102$2.9M
XENEXenon Pharmaceuticals Inc.49,050$2.9M
CLDXCelldex Therapeutics, Inc.89,397$2.8M
VERAVera Therapeutics, Inc.69,241$2.8M
PHVSPharvaris N.V.97,866$2.8M
VRDNViridian Therapeutics, Inc.\DE134,229$2.6M
ALKSAlkermes plc.73,189$2.6M
ALMSALUMIS INC.112,929$2.5M
TNGXTango Therapeutics, Inc.104,193$2.2M
GHGuardant Health Inc.23,357$2.2M
ASMBASSEMBLY BIOSCIENCES, INC.74,735$2.1M
JAZZJazz Pharmaceuticals plc10,838$2.0M
STOKStoke Therapeutics, Inc.62,617$2.0M
CMPSCOMPASS Pathways plc364,360$2.0M
IMCRImmunocore Holdings plc58,697$1.8M
OLMAOlema Pharmaceuticals, Inc.117,601$1.8M
KODKodiak Sciences Inc.43,569$1.7M
XOMAXOMA Royalty Corporation46,814$1.5M
RYTMRHYTHM PHARMACEUTICALS, INC.16,796$1.5M
MIRMMirum Pharmaceuticals, Inc.15,563$1.4M
SVRASavara Inc250,999$1.4M
MDGLMADRIGAL PHARMACEUTICALS, INC.2,598$1.4M
CTMXCytomX Therapeutics, Inc.288,057$1.4M
CGONCG Oncology, Inc.19,914$1.3M
BLTEBELITE BIO, INC8,033$1.3M
MLYSMineralys Therapeutics, Inc.46,778$1.3M
TVTXTravere Therapeutics, Inc.36,325$1.1M
NKTRNEKTAR THERAPEUTICS14,555$1.0M
UTHRUNITED THERAPEUTICS Corp1,514$898K
AVTXAvalo Therapeutics, Inc.58,622$875K
ZYMEZymeworks Inc.34,085$853K
PVLAPALVELLA THERAPEUTICS, INC.5,903$736K
BBOTBridgeBio Oncology Therapeutics, Inc.78,187$700K
JANXJanux Therapeutics, Inc.49,383$686K
NAMSNEWAMSTERDAM PHARMA CO N.V.20,067$642K
XNCRXencor Inc53,045$640K
TRVITrevi Therapeutics, Inc.53,525$639K
URGNUroGen Pharma Ltd.26,510$477K
KRYSKrystal Biotech, Inc.1,824$471K
MBXMBX Biosciences, Inc.11,472$342K
KYMRKymera Therapeutics, Inc.3,785$315K
CNTACentessa Pharmaceuticals plc5,964$237K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.